A

Aurinia Pharmaceuticals Inc.

315 employees

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Immunology
Drug Development
Lupus Nephritis
Biopharma
autoimmune
Nephrology
Medical
Health Care

Date founded

2013

Funding rounds raised

Total raised

$52M

from 9 investors over 9 rounds

A

Aurinia Pharmaceuticals Inc. raised $52M on February 14, 2014

Investors: Great Point Partners, venBio Partners, Lumira Ventures, RA Capital Management, L.P., Redmile Group, ATP (Apple Tree Partners) and Difference Capital Financial Inc.

A

Aurinia Pharmaceuticals Inc. raised $5.8M on September 23, 2013

Investors: Difference Capital Financial Inc. and Lumira Ventures

FAQ